These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9724087)
1. Screening of germline mutations in the CDK4, CDKN2C and TP53 genes in familial melanoma: a clinic-based population study. Platz A; Hansson J; Ringborg U Int J Cancer; 1998 Sep; 78(1):13-5. PubMed ID: 9724087 [TBL] [Abstract][Full Text] [Related]
2. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184 [TBL] [Abstract][Full Text] [Related]
3. A single nucleotide polymorphism in the 3'untranslated region of the CDKN2A gene is common in sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Kumar R; Smeds J; Berggren P; Straume O; Rozell BL; Akslen LA; Hemminki K Int J Cancer; 2001 Nov; 95(6):388-93. PubMed ID: 11668523 [TBL] [Abstract][Full Text] [Related]
4. Lack of germline CDK6 mutations in familial melanoma. Shennan MG; Badin AC; Walsh S; Summers A; From L; McKenzie M; Goldstein AM; Tucker MA; Hogg D; Lassam N Oncogene; 2000 Mar; 19(14):1849-52. PubMed ID: 10777219 [TBL] [Abstract][Full Text] [Related]
5. Investigation of germline PTEN, p53, p16(INK4A)/p14(ARF), and CDK4 alterations in familial glioma. Tachibana I; Smith JS; Sato K; Hosek SM; Kimmel DW; Jenkins RB Am J Med Genet; 2000 May; 92(2):136-41. PubMed ID: 10797439 [TBL] [Abstract][Full Text] [Related]
6. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Soufir N; Bressac-de Paillerets B; Desjardins L; Lévy C; Bombled J; Gorin I; Schlienger P; Stoppa-Lyonnet D Br J Cancer; 2000 Feb; 82(4):818-22. PubMed ID: 10732752 [TBL] [Abstract][Full Text] [Related]
7. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Tsao H; Zhang X; Kwitkiwski K; Finkelstein DM; Sober AJ; Haluska FG Arch Dermatol; 2000 Sep; 136(9):1118-22. PubMed ID: 10987867 [TBL] [Abstract][Full Text] [Related]
8. Rarity of CDK4 germline mutations in familial melanoma. Goldstein AM; Chidambaram A; Halpern A; Holly EA; Guerry IV D; Sagebiel R; Elder DE; Tucker MA Melanoma Res; 2002 Feb; 12(1):51-5. PubMed ID: 11828258 [TBL] [Abstract][Full Text] [Related]
9. Lack of germ-line mutations of CDK4, p16(INK4A), and p15(INK4B) in families with glioma. Gao L; Liu L; van Meyel D; Cairncross G; Forsyth P; Kimmel D; Jenkins RB; Lassam NJ; Hogg D Clin Cancer Res; 1997 Jun; 3(6):977-81. PubMed ID: 9815774 [TBL] [Abstract][Full Text] [Related]
10. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas. Boström J; Meyer-Puttlitz B; Wolter M; Blaschke B; Weber RG; Lichter P; Ichimura K; Collins VP; Reifenberger G Am J Pathol; 2001 Aug; 159(2):661-9. PubMed ID: 11485924 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a clinic-based population. FitzGerald MG; Harkin DP; Silva-Arrieta S; MacDonald DJ; Lucchina LC; Unsal H; O'Neill E; Koh J; Finkelstein DM; Isselbacher KJ; Sober AJ; Haber DA Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8541-5. PubMed ID: 8710906 [TBL] [Abstract][Full Text] [Related]
12. CDKN2A germ-line mutations in individuals with multiple cutaneous melanomas. Hashemi J; Platz A; Ueno T; Stierner U; Ringborg U; Hansson J Cancer Res; 2000 Dec; 60(24):6864-7. PubMed ID: 11156381 [TBL] [Abstract][Full Text] [Related]